Exec-Edge – Page 6 – ExecEdge

Ascentage Pharma Receives Clearance from China’s CDE for New Drug

Ascentage Pharma Receives Clearance from China’s CDE for New Drug

By Exec Edge Editorial Staff Ascentage Pharma said China’s Center for Drug Evaluation has cleared its investigational new drug application for APG-3288, a next-generation Bruton’s tyrosine kinase (BTK) protein degrader, paving the way for clinical testing in the country and...

Input your search keywords and press Enter.